This was a landmark year for the lupus community and the Lupus Research Alliance. Hear from Lupus Research Alliance President and CEO Albert T. Roy about how we’re pushing the boundaries of scientific innovation and advancing pioneering research to realize our vision: a world free of lupus.

Al highlights the advances in next-generation diagnostics and curative treatments—including potential engineered cell therapies and precision medicine and active involvement in dozens of clinical trials. He also shares the tremendous progress from the first public-private partnership in lupus convened by the Lupus Research Alliance with the U.S. Food and Drug Administration and the lupus community to address common obstacles and integrate patient priorities in the drug development process. Fueled by the support of the community, the Lupus Research Alliance remains steadfast in our commitment to support the full continuum of lupus research—from groundbreaking discoveries in the lab to clinical breakthroughs. Every program the Lupus Research Alliance invests in is a catalyst, accelerating progress toward personalized treatments and a cure.